Preconceived ideas, paradoxes, and new concepts in retinal vein occlusion

被引:3
作者
Glacet-Bernard, A. [1 ]
Coscas, G. [1 ]
Pournaras, C. -J. [2 ]
机构
[1] Univ Paris Est Creteil, Serv Univ Ophtalmol, Hop Intercommunal, Hop Henri Mondor,Assistance Publ Hop Paris, F-94000 Creteil, France
[2] Univ Geneva, Hop Cantonal, CH-1211 Geneva 4, Switzerland
来源
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2011年 / 34卷 / 08期
关键词
Retinal vein occlusion; Vascular risk factors; Macular edema; Retinal ischemia; Fluorescein angiography; Optical coherence tomography; ONSET;
D O I
10.1016/j.jfo.2011.04.010
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Retinal vein occlusion is the second cause of vascular retinopathy after diabetic retinopathy and often leads to poor visual outcome. In a simplified form, the authors attempt to rectify a number of preconceived ideas about retinal vein occlusion and introduce new concepts in order to assist in the understanding of their mechanisms. Various paradoxes are explained, such as the presence of arterial risk factors in this venous disorder, the atypical combination of retinal ischemia and the absence of vascular non-perfusion on fluorescein angiography, the fact that macular edema is larger in the ischemic form than in the well-perfused form, the aggravating role of contraceptive hormonal therapy, the protective role of substitutive hormonal therapy, etc. The current controversies are underlined: the seasonal onset of the disease, the role of vasodilator treatment, the place of etiologic screening, and the significance of pre-papillary loops. Lastly, the authors summarize important basics about treatment modalities, even if there is not yet consensus on the treatment of retinal vein occlusion. (C) 2011 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:583 / 588
页数:6
相关论文
共 39 条
[1]  
[Anonymous], 1996, ARCH OPHTHALMOL-CHIC, DOI DOI 10.1001/ARCHOPHT.1996.01100130537006
[2]  
Boyer D, 2010, OPHTHALMOLOGY, V117, P1860, DOI 10.1016/j.ophtha.2010.02.022
[3]   Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion Six-Month Primary End Point Results of a Phase III Study [J].
Campochiaro, Peter A. ;
Heier, Jeffrey S. ;
Feiner, Leonard ;
Gray, Sarah ;
Saroj, Namrata ;
Rundle, Amy Chen ;
Murahashi, Wendy Yee ;
Rubio, Roman G. .
OPHTHALMOLOGY, 2010, 117 (06) :1102-U111
[4]  
Clarkson JC, 1997, ARCH OPHTHALMOL-CHIC, V115, P486
[5]  
CLARKSON JG, 1995, OPHTHALMOLOGY, V102, P1425
[6]  
Coscas G., 1978, OCCLUSIONS VEINEUSES
[7]   Retinal vein occlusions in patients treated with anticoagulant and/or platelet aggregation inhibitors. Five case studies [J].
de Lahitte, G. Ducos ;
Quintyn, J. C. ;
Leparmentier, A. ;
Mathis, A. .
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2007, 30 (02) :145-149
[8]  
Donati G, 1997, INVEST OPHTH VIS SCI, V38, P1450
[9]   CENTRAL RETINAL VEIN OCCLUSION IN YOUNG-ADULTS [J].
FONG, ACO ;
SCHATZ, H .
SURVEY OF OPHTHALMOLOGY, 1993, 37 (06) :393-417
[10]   Retinochoroidal collateral veins protect against anterior segment neovascularization after central retinal vein occlusion [J].
Fuller, JJ ;
Mason, JO ;
White, MF ;
McGwin, G ;
Emond, TL ;
Feist, RM .
ARCHIVES OF OPHTHALMOLOGY, 2003, 121 (03) :332-336